Fig. 3

Survival and ROC analysis. Overall survival (OS) for 53 patients with respect to histopathologic tumor regression (a), miR-194* (c) and miR-665 expression (d). Receiver operating characteristic (ROC) curves (b) for the histopathological non-response to RCTX stratified by high miRNA-194* and miRNA-665 expression, respectively